Effects of beta-cell rest on beta-cell function: a review of clinical and preclinical data

Jackson RL, 1940, Am J Dis Child, 59, 332

10.1007/BF01219420

10.1016/S0140-6736(76)91473-2

Palmer JP, 2002, Ann N Y Acad Sci, 958, 89, 10.1111/j.1749-6632.2002.tb02950.x

10.1056/NEJMp078030

10.1172/JCI28898

10.1210/er.2001-0039

10.2337/diabetes.53.8.1942

10.2337/diabetes.51.2007.S389

10.1007/s00125-003-1153-1

10.1016/j.cmet.2006.01.004

Hansen JB, 2004, Curr Med Chem, 11, 1595, 10.2174/0929867043365026

10.1111/j.1749-6632.1968.tb19045.x

10.1034/j.1399-5448.2001.002003115.x

Gurrath MM, 2001, Curr Med Chem, 8, 1605, 10.2174/0929867013371798

10.1210/jc.2002-030003

10.1210/en.141.1.111

10.1016/S0006-2952(99)00010-6

10.1006/bbrc.1994.2670

10.1210/jc.2003-031120

10.1074/jbc.M112478200

10.2337/diabetes.54.9.2602

10.1530/eje.0.1460871

10.2337/diabetes.52.8.2043

10.1002/jcb.21222

Buschard K, 1988, APMIS, 96, 342, 10.1111/j.1699-0463.1988.tb05313.x

Karlsson FA, 1997, Autoimmunity, 26, 117, 10.3109/08916939709003855

10.1210/jc.75.6.1574

10.1210/en.132.6.2674

10.1074/jbc.M606118200

10.1210/en.143.2.339

10.1016/j.metabol.2006.01.003

10.1172/JCI25385

10.1016/j.immuni.2005.08.002

Matveyenko AV, 2006, ILAR J, 47, 225, 10.1093/ilar.47.3.225

10.1007/BF00703140

10.1016/0026-0495(91)90010-T

Zhou YS, 2004, Chin Med J (Engl), 117, 1523

10.2337/diabetes.36.8.971

10.1152/ajpendo.00255.2004

10.2337/diabetes.53.7.1706

10.2337/diabetes.53.4.1089

Rasmussen SB, 2000, Horm Metab Res, 32, 294, 10.1055/s-2007-978639

10.2337/diabetes.43.2.173

10.2337/diabetes.49.7.1131

The Diabetes Control and Complications Trial Research Group, 1998, Ann Intern Med, 128, 517, 10.7326/0003-4819-128-7-199804010-00001

10.2337/diacare.26.3.832

10.1056/NEJMoa012350

10.2337/diacare.28.7.1630

10.1530/eje.0.1490223

51. NationalInstitute ofDiabetes andDigestive andKidneyDiseaseset al. Oral insulin for prevention of diabetes in relatives at risk for type 1 diabetes mellitus . In: ClinicalTrials.gov. Bethesda, MD: National Library of Medicine (US), 2000, NLM identifier NCT00419562. (available fromhttp://www.clinicaltrials.gov/ct/show/NCT00419562). Accessed 5 July 2007.

Glaser B, 1988, Acta Endocrinol (Copenh), 118, 365, 10.1530/acta.0.1180365

Sellers EA, 2004, J Pediatr Endocrinol Metab, 17, 1561, 10.1515/JPEM.2004.17.11.1561

10.2337/diacare.27.5.1028

10.2337/diacare.27.11.2597

10.2337/diacare.20.9.1353

57. NationalInstitute ofDiabetes andDigestive andKidneyDiseases. Effect of short-term beta-cell rest in adolescents and young adults with type 2 diabetes mellitus . In: ClinicalTrials.gov. Bethesda, MD: National Library of Medicine (US), 2000, NLM identifier NCT00445627. (available fromhttp://www.clinicaltrials.gov/ct/show/NCT00445627). Accessed 5 July 2007.

10.2337/diabetes.45.10.1427

59. V Grill. Efficacy of diazoxide in type 1 diabetes . In: ClinicalTrials.gov. Bethesda, MD: National Library of Medicine (US), 2000, NLM identifier NCT00131755. (available fromhttp://www.clinicaltrials.gov/ct/show/NCT00131755). Accessed 5 July 2007.

Guldstrand M, 2002, Diabetes Metab, 28, 448

Laedtke T, 2000, Am J Physiol Endocrinol Metab, 279, E520, 10.1152/ajpendo.2000.279.3.E520

Candrina R, 1988, J Endocrinol Invest, 11, 501, 10.1007/BF03350169

Grunt JA, 1994, J Pediatr Endocrinol, 7, 331, 10.1515/JPEM.1994.7.4.331

10.2337/diacare.21.3.427

10.1074/jbc.273.50.33501

10.1210/jc.2004-0699

10.1001/jama.281.21.2005